James L. Velianou

5.3k total citations
67 papers, 1.6k citations indexed

About

James L. Velianou is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, James L. Velianou has authored 67 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Cardiology and Cardiovascular Medicine, 30 papers in Surgery and 20 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in James L. Velianou's work include Acute Myocardial Infarction Research (25 papers), Coronary Interventions and Diagnostics (22 papers) and Cardiac Valve Diseases and Treatments (21 papers). James L. Velianou is often cited by papers focused on Acute Myocardial Infarction Research (25 papers), Coronary Interventions and Diagnostics (22 papers) and Cardiac Valve Diseases and Treatments (21 papers). James L. Velianou collaborates with scholars based in Canada, United States and United Kingdom. James L. Velianou's co-authors include Madhu K. Natarajan, Shamir R. Mehta, Warren J. Cantor, Peter B. Berger, David R. Holmes, Madhu K. Natarajan, John G. Webb, Harindra C. Wijeysundera, Anson Cheung and Catherine Kreatsoulas and has published in prestigious journals such as Circulation, Annals of Internal Medicine and Journal of the American College of Cardiology.

In The Last Decade

James L. Velianou

64 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James L. Velianou Canada 20 1.2k 669 489 367 311 67 1.6k
Rahul Sakhuja United States 20 1.3k 1.1× 710 1.1× 438 0.9× 328 0.9× 382 1.2× 66 1.9k
Romain Chopard France 21 961 0.8× 531 0.8× 251 0.5× 422 1.1× 324 1.0× 80 1.6k
Robert Stoler United States 23 889 0.7× 494 0.7× 406 0.8× 201 0.5× 255 0.8× 78 1.3k
Yohei Numasawa Japan 21 917 0.8× 607 0.9× 284 0.6× 307 0.8× 124 0.4× 123 1.4k
Andrew C. Eisenhauer United States 23 1.2k 1.0× 631 0.9× 993 2.0× 216 0.6× 509 1.6× 54 2.0k
Hana Vaknin‐Assa Israel 22 1.4k 1.2× 787 1.2× 304 0.6× 530 1.4× 375 1.2× 143 1.7k
Anupama Rao United States 16 1.0k 0.9× 527 0.8× 254 0.5× 144 0.4× 150 0.5× 51 1.5k
Francesco Summaria Italy 16 951 0.8× 766 1.1× 892 1.8× 213 0.6× 251 0.8× 47 1.7k
Nevio Taglieri Italy 25 1.2k 1.0× 564 0.8× 394 0.8× 379 1.0× 385 1.2× 91 1.7k
Süleyman Karakoyun Türkiye 20 1.2k 1.0× 500 0.7× 247 0.5× 262 0.7× 587 1.9× 103 1.6k

Countries citing papers authored by James L. Velianou

Since Specialization
Citations

This map shows the geographic impact of James L. Velianou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James L. Velianou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James L. Velianou more than expected).

Fields of papers citing papers by James L. Velianou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James L. Velianou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James L. Velianou. The network helps show where James L. Velianou may publish in the future.

Co-authorship network of co-authors of James L. Velianou

This figure shows the co-authorship network connecting the top 25 collaborators of James L. Velianou. A scholar is included among the top collaborators of James L. Velianou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James L. Velianou. James L. Velianou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Styra, Rima, Patrick Magloire, Jon-David Schwalm, et al.. (2025). JUMPSTART: evaluation of an early mobilization program following transcatheter aortic valve replacement. BMC Cardiovascular Disorders. 25(1). 216–216.
2.
Mehta, Shamir R, Natalia Pinilla‐Echeverri, Tej Sheth, et al.. (2025). Intracoronary Low-Dose Recombinant Tissue Plasminogen Activator in Primary PCI for ST-Segment Elevation Myocardial Infarction and Large Thrombus Burden. Journal of the American College of Cardiology. 87(3). 238–248. 1 indexed citations
3.
Butala, Neel M., David Wood, Haiyan Li, et al.. (2022). Economics of Minimalist Transcatheter Aortic Valve Replacement: Results From the 3M-TAVR Economic Study. Circulation Cardiovascular Interventions. 15(10). e012168–e012168. 9 indexed citations
4.
Natarajan, Madhu K., Tej Sheth, Harindra C. Wijeysundera, et al.. (2021). REMOTE ECG MONITORING TO REDUCE COMPLICATIONS FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATIONS - THE REDIRECT TAVI STUDY. Journal of the American College of Cardiology. 77(18). 1126–1126.
5.
Jolly, Sanjit S., John A. Cairns, Shahar Lavi, et al.. (2018). Thrombus Aspiration in Patients With High Thrombus Burden in the TOTAL Trial. Journal of the American College of Cardiology. 72(14). 1589–1596. 58 indexed citations
7.
Ko, Dennis T., Harindra C. Wijeysundera, Jacob A. Udell, et al.. (2014). Traditional Cardiovascular Risk Factors and the Presence of Obstructive Coronary Artery Disease in Men and Women. Canadian Journal of Cardiology. 30(7). 820–826. 21 indexed citations
8.
Bainey, Kevin R., Madhu K. Natarajan, Mathew Mercuri, et al.. (2013). Treatment Assignment of High-Risk Symptomatic Severe Aortic Stenosis Patients Referred for Transcatheter AorticValve Implantation. The American Journal of Cardiology. 112(1). 100–103. 12 indexed citations
9.
Mercuri, Mathew, Gerald Moran, Leslie Gauthier, et al.. (2013). Radiation Dose in Interventional Cardiology Procedures: Urgent Need for Monitoring Dose and Establishing Diagnostic Reference Levels. Healthcare Quarterly. 11(1). 76–83. 6 indexed citations
10.
11.
Alazzoni, Ashraf, James L. Velianou, & Sanjit S. Jolly. (2011). Left main thrombus as a complication of thrombectomy during primary percutaneous coronary intervention.. PubMed. 23(2). E9–11. 4 indexed citations
12.
Mercuri, Mathew, James L. Velianou, Michelle Welsford, Leslie Gauthier, & Madhu K. Natarajan. (2010). Improving the Timeliness of Care for Patients with Acute ST-Elevation Myocardial Infarction: Implications of "Self-Transport" versus Use of EMS. Healthcare Quarterly. 13(1). 105–109. 8 indexed citations
13.
Kreatsoulas, Catherine, Madhu K. Natarajan, Rutaba Khatun, James L. Velianou, & Sonia S. Anand. (2009). Identifying women with severe angiographic coronary disease. Journal of Internal Medicine. 268(1). 66–74. 21 indexed citations
14.
Schwalm, Jon-David, et al.. (2008). Cardiogenic shock following nasal septoplasty: a case report and review of the literature. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 55(6). 376–379. 18 indexed citations
15.
Velianou, James L., et al.. (2008). Comparison of one-year clinical outcomes with paclitaxel-eluting stents versus bare metal stents in everyday practice. Canadian Journal of Cardiology. 24(10). 771–775. 2 indexed citations
16.
Velianou, James L., et al.. (2006). Primary and Rescue Percutaneous Coronary Intervention With Paclitaxel-Eluting Stent Implantation in ST-Elevation Myocardial Infarction. The American Journal of Cardiology. 97(9). 1308–1310. 10 indexed citations
17.
Natarajan, Madhu K., Catherine Kreatsoulas, James L. Velianou, et al.. (2004). Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions. The American Journal of Cardiology. 93(6). 750–753. 56 indexed citations
18.
Berger, Peter B., James L. Velianou, Helen Vlachos, et al.. (2001). Survival following coronary angioplasty versus coronary artery bypass surgery in anatomic subsets in which coronary artery bypass surgery improves survival compared with medical therapy. Journal of the American College of Cardiology. 38(5). 1440–1449. 48 indexed citations
19.
Velianou, James L., Verghese Mathew, Stephanie H. Wilson, et al.. (2000). Effect of abciximab on late adverse events in patients with diabetes mellitus undergoing stent implantation. The American Journal of Cardiology. 86(10). 1063–1068. 9 indexed citations
20.
Velianou, James L., et al.. (2000). Evaluation of the role of abciximab (Reopro) as a rescue agent during percutaneous coronary interventions: In-hospital and six-month outcomes. Catheterization and Cardiovascular Interventions. 51(2). 138–144. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026